Dundee researchers develop 'automatic drug designer'

Drugs Researchers say an automated design system could create drugs quickly and cheaply

Related Stories

Researchers at the University of Dundee believe a new automated design system could create drugs quicker and cheaper than currently possible.

The scientists have adapted the "Moneyball" approach, which uses the principles of advanced statistical and data analysis to speed up research.

They used a computer to test the evolution of drug molecules and found their predictions to be 75% correct.

The technique could lead to new cheaper and safer treatments for illness.

The University of Dundee researchers are trialling the system on the creation of drugs to treat infectious diseases.

Evolved solution

Chair of Medicinal Informatics at Dundee Prof Andrew Hopkins said: "One of the things that makes drug discovery so hard is that you're trying to improve several different properties at the same time.

Start Quote

The system mimics the design process of human chemists but runs it on a very large scale at a faster rate”

End Quote Prof Andrew Hopkins University of Dundee

"Evolution is a mechanism that can be applied to solving these kinds of problems, and the iterative (repeating) process of adaptation and selection of hundreds of thousand of possible solutions can be simulated in a computer.

"We have effectively proved the concept of automated design of new compounds showing that by using algorithms to process massive amounts of data, we can tackle problems of huge complexity."

Prof Hopkins said there were very real implications from the research.

Faster process

"Potentially the system could make the process of drug creation more efficient by reducing failure rates in testing and showing chemists which of the potential thousands of solutions would be best-suited to their problem," he added.

"The system mimics the design process of human chemists but runs it on a very large scale at a faster rate."

Prof Hopkins and colleagues used the drug donepezil, used to treat people with Alzheimer's disease, to test the automated system.

He said: "We took the structure of donepezil as a starting point and from there the system evolved its structure over many generations to a variety of different profiles across a range of drug targets.

"The predicted profiles were then tested experimentally and we found that 75% of them were confirmed to be correct.

"This proof of concept shows that we could make significant advances in discovering and designing complex drugs, which could lead to improvements in safety and efficacy, while also potentially reducing the cost of drug discovery which is a high-risk and expensive process."

The research was funded by the Biotechnology and Biological Sciences Research Council and is published in the Nature journal.

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

BBC Tayside & Central



Min. Night 4 °C

Features & Analysis

Elsewhere on the BBC

  • Audi R8Need for speed

    Audi unveils its fastest production car ever - ahead of its Geneva debut


  • A robot holding a table legClick Watch

    The robots who build flat-pack furniture - teaching machines to work collaboratively

Try our new site and tell us what you think. Learn more
Take me there

Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.